These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Effect of 'Mentat' on the pharmacokinetics of single and multiple doses o phenytoin in rabbits. Garg SK; Islam AS; Kumar N; Sehgal M; Bhargava VK Neurol India; 1999 Jun; 47(2):104-7. PubMed ID: 10402333 [TBL] [Abstract][Full Text] [Related]
12. Fosphenytoin for seizure control. Hutt N Am J Nurs; 1999 Mar; 99(3):52. PubMed ID: 10091570 [No Abstract] [Full Text] [Related]
13. Phenytoin penetration into brain after administration of phenytoin or fosphenytoin. Walton NY; Uthman BM; El Yafi K; Kim JM; Treiman DM Epilepsia; 1999 Feb; 40(2):153-6. PubMed ID: 9952260 [TBL] [Abstract][Full Text] [Related]
14. Drug-drug interactions among drugs prescribed for nontuberculous mycobacterial infection and epilepsy: A case report. Yoshikawa N; Tazaki T; Hatanaka M; Oda Y; Matsumoto N; Sonoda J; Ikeda R J Clin Pharm Ther; 2019 Feb; 44(1):119-121. PubMed ID: 30311244 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of parenteral use of antiepileptic drugs. Bialer M Epilepsia; 2007; 48 Suppl 8():46-8. PubMed ID: 18329998 [No Abstract] [Full Text] [Related]
16. Antiepileptic drugs in developing countries. Trevathan E; Medina MT; Madrid A Lancet; 1998 Apr; 351(9110):1210-1. PubMed ID: 9643725 [No Abstract] [Full Text] [Related]
17. Lack of pharmacokinetic interaction between zileuton and phenytoin in humans. Samara E; Cavanaugh JH; Mukherjee D; Granneman GR Clin Pharmacokinet; 1995; 29 Suppl 2():84-91. PubMed ID: 8620675 [TBL] [Abstract][Full Text] [Related]
18. Lower phenytoin serum levels in persons switched from brand to generic phenytoin. Burkhardt RT; Leppik IE; Blesi K; Scott S; Gapany SR; Cloyd JC Neurology; 2004 Oct; 63(8):1494-6. PubMed ID: 15505173 [TBL] [Abstract][Full Text] [Related]
19. Problems with phenytoin administration in neurology/neurosurgery ITU patients receiving enteral feeding. Kitchen D; Smith D Seizure; 2001 Jun; 10(4):265-8. PubMed ID: 11466022 [TBL] [Abstract][Full Text] [Related]
20. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects. Franco V; Perucca E Expert Opin Drug Metab Toxicol; 2015; 11(8):1269-79. PubMed ID: 26037375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]